title: Pulmonary pressure-flow relation as a determinant factor of exercise capacity and symptoms in patients with regurgitant valvular heart disease.
abstract: BACKGROUND
  Exertional dyspnea is a frequent limiting symptom in patients with chronic heart failure. Furthermore, dyspnea and a plateau in VO(2) (oxygen consumption) at peak exercise often co-exist in chronic heart failure, especially in patients with severe regurgitant valvular heart disease (RVHD), their relevance to hemodynamics and subjective symptoms during exercise have not been fully understood.
  
  
  OBJECTIVE
  The purpose of this study was to examine the determinant factor of exercise capacity in patients with RVHD.
  
  
  METHODS
  We performed a symptom-limited cardiopulmonary exercise test using a sitting cycle ergometer with right heart catheterization in 20 patients with severe RVHD. VO(2) and hemodynamics were measured at rest and during exercise, and symptomatic end-point at peak exercise was evaluated by using Borg's score.
  
  
  RESULTS
  Of the 20 patients, 11 attained a plateau in VO(2) at peak exercise (Group 1). At peak exercise, pulmonary arterial pressure (PAP) was higher, and cardiac output (CO) and VO(2) were lower in Group 1 than in patients without a plateau in VO(2) (Group 2) (mean PAP: 60+/-10 vs. 48+/-9 mm Hg, P=0.05; CO: 8.3+/-2.6 vs. 11.2+/-2.6 l/min, P=0.01; VO(2): 1059+/-259 vs. 1359+/-328 ml/min, P=0.01). In Group 1, 6 patients complaining of dyspnea rather than leg fatigue at peak exercise had lower CO (7.1+/-1.8 vs. 9.7+/-3.0 l/min, P=0.05) and higher slope of mean PAP-CO relation (P-Q slope) (10.6+/-3.6 vs. 5.4+/-1.7, P=0.01), compared with the other 5 patients with leg fatigue.
  
  
  CONCLUSIONS
  Development of pulmonary hypertension during exercise is the important limiting factor for exercise capacity in patients with RVHD. The limitation of increase in CO concomitant with pulmonary hypertension could be an important factor in the appearance of dyspnea.
authors.affiliation: Division of Cardiology, Department of Medicine, Jikei University School of Medicine, Japan.
authors.forename: Toshio
authors.initials: T
authors.lastname: Hasuda
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Okano
authors.forename: Takao
authors.initials: T
authors.lastname: Yoshioka
authors.forename: Norifumi
authors.initials: N
authors.lastname: Nakanishi
authors.forename: Mituyuki
authors.initials: M
authors.lastname: Shimizu
mesh_terms: D001022:Aortic Valve Insufficiency / Q000453:epidemiology / Q000503:physiopathology*; D015897:Comorbidity; D004417:Dyspnea / Q000503:physiopathology; D005080:Exercise Test; D017079:Exercise Tolerance / Q000502:physiology*; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000453:epidemiology / Q000503:physiopathology*; D010101:Oxygen Consumption; D011651:Pulmonary Artery / Q000503:physiopathology